Serum uric acid and resistance to antihypertensive treatment: data from the European Lacidipine Study on Atherosclerosis

Michele Bombelli,Mario Macchiarulo,Rita Facchetti,Davide Maggiolini,Cesare Cuspidi,Gianfranco Parati,Giuseppe Mancia,Guido Grassi

Serum uric acid and resistance to antihypertensive treatment: data from the European Lacidipine Study on Atherosclerosis

2019

Michele Bombelli
Mario Macchiarulo
Rita Facchetti
Davide Maggiolini
Cesare Cuspidi
Gianfranco Parati
Giuseppe Mancia
Guido Grassi

Aim:Whether increased serum uric acid (SUA) favours resistance to antihypertensive drugs is not clear.Methods:The European Lacidipine Study on Atherosclerosis (ELSA) was a randomized, double-blind, multicenter trial comparing the effects of a 4-year treatment with either lacidipine or atenolol on pr

Keywords:

Endocrinology
Diabetes mellitus
Medicine
Lacidipine
Internal medicine
Uric acid
Multicenter trial
Atenolol
serum uric acid
Increased serum uric acid

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations